BR9911344A - Composto, undecanoato de ment, uso do mesmo, formulação farmacêutica, e, kit para a contracepção masculina. - Google Patents
Composto, undecanoato de ment, uso do mesmo, formulação farmacêutica, e, kit para a contracepção masculina.Info
- Publication number
- BR9911344A BR9911344A BR9911344-9A BR9911344A BR9911344A BR 9911344 A BR9911344 A BR 9911344A BR 9911344 A BR9911344 A BR 9911344A BR 9911344 A BR9911344 A BR 9911344A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- kit
- pharmaceutical formulation
- male contraception
- ment undecanoate
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- YSGQGNQWBLYHPE-CFUSNLFHSA-N (7r,8r,9s,10r,13s,14s,17s)-17-hydroxy-7,13-dimethyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-one Chemical compound C1C[C@]2(C)[C@@H](O)CC[C@H]2[C@@H]2[C@H](C)CC3=CC(=O)CC[C@@H]3[C@H]21 YSGQGNQWBLYHPE-CFUSNLFHSA-N 0.000 abstract 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 abstract 2
- JFEPJTGMGDGPHJ-PNKHAZJDSA-N (8r,9s,10r,13s,14s)-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-one Chemical compound C1CC2=CC(=O)CC[C@@H]2[C@@H]2[C@@H]1[C@@H]1CCC[C@@]1(C)CC2 JFEPJTGMGDGPHJ-PNKHAZJDSA-N 0.000 abstract 1
- -1 1 -oxoundecyl Chemical group 0.000 abstract 1
- 239000003098 androgen Substances 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 229960003604 testosterone Drugs 0.000 abstract 1
- 150000003515 testosterones Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0074—Esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cultivation Receptacles Or Flower-Pots, Or Pots For Seedlings (AREA)
- Percussion Or Vibration Massage (AREA)
- Medicinal Preparation (AREA)
Abstract
"COMPOSTO, UNDECANOATO DE MENT, USO DO MESMO, FORMULAçãO FARMACêUTICA, E, KIT PARA A CONTRACEPçãO MASCULINA" A invenção refere-se ao novo andrógeno (7<244>, 7 <225>) -7-metil-17[(1-oxoundecil)oxi]estr-4-en-3-ona ( undecanoato de MENT). Este composto se distingue favoravelmente de outros derivados de testosterona pelo fato de que ele possui uma boa solubilidade em meios oleosos. Ele exibe particularmente uma boa potência dissolvida em relação à testosterona. O composto é particularmente adequado para a administração por meio de injeção.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98202052 | 1998-06-19 | ||
| PCT/EP1999/004102 WO1999067271A1 (en) | 1998-06-19 | 1999-06-14 | Testosterone derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9911344A true BR9911344A (pt) | 2001-03-13 |
Family
ID=8233831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9911344-9A BR9911344A (pt) | 1998-06-19 | 1999-06-14 | Composto, undecanoato de ment, uso do mesmo, formulação farmacêutica, e, kit para a contracepção masculina. |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US6437158B1 (pt) |
| EP (1) | EP1087986B1 (pt) |
| JP (1) | JP2002518514A (pt) |
| KR (1) | KR100596649B1 (pt) |
| CN (1) | CN1172949C (pt) |
| AT (1) | ATE215961T1 (pt) |
| AU (1) | AU756739B2 (pt) |
| BR (1) | BR9911344A (pt) |
| CA (1) | CA2333985C (pt) |
| CZ (1) | CZ293319B6 (pt) |
| DE (1) | DE69901250T2 (pt) |
| DK (1) | DK1087986T3 (pt) |
| ES (1) | ES2175989T3 (pt) |
| HU (1) | HUP0102274A3 (pt) |
| ID (1) | ID27260A (pt) |
| IL (1) | IL139689A (pt) |
| NO (1) | NO316518B1 (pt) |
| NZ (1) | NZ508299A (pt) |
| PL (1) | PL191285B1 (pt) |
| PT (1) | PT1087986E (pt) |
| RU (1) | RU2216546C2 (pt) |
| SK (1) | SK282796B6 (pt) |
| TR (1) | TR200003743T2 (pt) |
| WO (1) | WO1999067271A1 (pt) |
| ZA (1) | ZA200006813B (pt) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6756366B1 (en) * | 1999-04-06 | 2004-06-29 | Akzo Nobel N.V. | Orally active androgens |
| IL153934A0 (en) * | 2000-07-28 | 2003-07-31 | Akzo Nobel Nv | 16 alpha-methyl or ethyl substituted estrogens |
| JP3774888B2 (ja) * | 2001-11-28 | 2006-05-17 | 日本化薬株式会社 | ステロイド類化合物のｌｃ−ｍｓによる高感度検出法 |
| TW200403065A (en) | 2002-05-30 | 2004-03-01 | Akzo Nobel Nv | New etonogestrel esters |
| TW200400041A (en) * | 2002-05-30 | 2004-01-01 | Akzo Nobel Nv | Use of new etonogestrel esters |
| TW200404552A (en) * | 2002-05-30 | 2004-04-01 | Akzo Nobel Nv | Self administered contraception |
| GB0304927D0 (en) | 2003-03-04 | 2003-04-09 | Resolution Chemicals Ltd | Process for the production of tibolone |
| JO2505B1 (en) | 2003-03-14 | 2009-10-05 | باير شيرنغ فارما اكتنجيسيلشافت | Pharmacy methods and formulations for obtaining acceptable serum testosterone levels |
| JO2492B1 (en) | 2003-04-28 | 2009-10-05 | شيرينج ايه جي | A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients |
| PE20050677A1 (es) | 2003-12-22 | 2005-10-04 | Akzo Nobel Nv | Esteroides con perfil androgenico y progestagenico mixto |
| UA89964C2 (ru) | 2004-09-08 | 2010-03-25 | Н.В. Органон | 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ |
| EP1879382B1 (en) | 2006-07-10 | 2017-09-06 | Samsung Electronics Co., Ltd. | Multi-screen display apparatus and method for digital broadcast receiver |
| WO2008101030A1 (en) * | 2007-02-13 | 2008-08-21 | The Regents Of The University Of California | Methods for amplifying steroid hormone effects |
| US20090017107A1 (en) * | 2007-07-13 | 2009-01-15 | Oral Delivery Technology Ltd. | Novel composition to increase libido |
| US20090018107A1 (en) * | 2007-07-13 | 2009-01-15 | Oral Delivery Technology Ltd. | Novel composition to increase muscle strength |
| US20100303937A1 (en) * | 2009-06-01 | 2010-12-02 | Michael Farber | Novel composition to increase testosterone levels |
| CN102558267A (zh) * | 2012-01-13 | 2012-07-11 | 宜城市共同药业有限公司 | 庚酸睾酮的制备方法 |
| EP4186545A1 (en) | 2012-04-06 | 2023-05-31 | Antares Pharma, Inc. | Needle assisted jet injection administration of testosterone compositions |
| DK3659647T3 (da) * | 2013-02-11 | 2024-04-22 | Antares Pharma Inc | Nålestøttet jetinjektionsindretning med reduceret udløserkraft |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5342834A (en) * | 1989-04-07 | 1994-08-30 | The Population Council, Inc. | Method for androgen supplementation |
-
1999
- 1999-06-14 SK SK1940-2000A patent/SK282796B6/sk not_active IP Right Cessation
- 1999-06-14 DE DE69901250T patent/DE69901250T2/de not_active Expired - Fee Related
- 1999-06-14 CN CNB998075175A patent/CN1172949C/zh not_active Expired - Fee Related
- 1999-06-14 TR TR2000/03743T patent/TR200003743T2/xx unknown
- 1999-06-14 EP EP99929208A patent/EP1087986B1/en not_active Expired - Lifetime
- 1999-06-14 RU RU2001101892/04A patent/RU2216546C2/ru not_active IP Right Cessation
- 1999-06-14 BR BR9911344-9A patent/BR9911344A/pt not_active Application Discontinuation
- 1999-06-14 PL PL344987A patent/PL191285B1/pl not_active IP Right Cessation
- 1999-06-14 CZ CZ20004779A patent/CZ293319B6/cs not_active IP Right Cessation
- 1999-06-14 HU HU0102274A patent/HUP0102274A3/hu unknown
- 1999-06-14 ID IDW20002632A patent/ID27260A/id unknown
- 1999-06-14 AU AU46101/99A patent/AU756739B2/en not_active Ceased
- 1999-06-14 CA CA002333985A patent/CA2333985C/en not_active Expired - Fee Related
- 1999-06-14 AT AT99929208T patent/ATE215961T1/de not_active IP Right Cessation
- 1999-06-14 PT PT99929208T patent/PT1087986E/pt unknown
- 1999-06-14 DK DK99929208T patent/DK1087986T3/da active
- 1999-06-14 JP JP2000555922A patent/JP2002518514A/ja active Pending
- 1999-06-14 ES ES99929208T patent/ES2175989T3/es not_active Expired - Lifetime
- 1999-06-14 IL IL13968999A patent/IL139689A/en not_active IP Right Cessation
- 1999-06-14 WO PCT/EP1999/004102 patent/WO1999067271A1/en not_active Ceased
- 1999-06-14 NZ NZ508299A patent/NZ508299A/xx unknown
- 1999-06-14 KR KR1020007014182A patent/KR100596649B1/ko not_active Expired - Fee Related
- 1999-06-14 US US09/719,927 patent/US6437158B1/en not_active Expired - Fee Related
-
2000
- 2000-11-21 ZA ZA200006813A patent/ZA200006813B/en unknown
- 2000-12-18 NO NO20006455A patent/NO316518B1/no unknown
-
2002
- 2002-06-21 US US10/177,989 patent/US20040033999A1/en not_active Abandoned
-
2004
- 2004-10-13 US US10/964,076 patent/US6989378B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9911344A (pt) | Composto, undecanoato de ment, uso do mesmo, formulação farmacêutica, e, kit para a contracepção masculina. | |
| BR0107445A (pt) | Formulação farmacêutica, uso de fulvestrante na preparação de uma formulação farmacêutica, e, seringa ou frasco | |
| BR0111639A (pt) | Uso de uma molécula de ácido oligodeoxinucléico, e composição farmacêutica contendo a mesma | |
| EP2348032A3 (en) | 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothiotic acid s-fluoromethyl ester as an anti-inflammatory agent | |
| MX9301032A (es) | Compuestos farmaceuticos y procedimento para su preparacion | |
| ITMI921601A1 (it) | Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci. | |
| KR950700894A (ko) | 탁솔 유도체(Taxol derivatives) | |
| CO5040216A1 (es) | Agonistas de adenosina a 1, proceso para su preparacion y composiciones farmaceuticas que los contienen | |
| KR920701200A (ko) | 신규의 4h-3,1-벤조옥사진-4-온 유도체 | |
| AU3559193A (en) | New 3',5'-di-tert-butyl-4'-hydroxy flavones, process for the preparation thereof and pharmaceutical compositions containing them | |
| NO800447L (no) | Derivater av difenylhydantoin, farmasoeytiske preparater inneholdende slike preparater, samt fremgangsmaate til fremstilling av de aktive forbindelser | |
| ZA881030B (en) | 19-nor steroids substituted in position 7,their preparation,application as medicaments,compositions containing them | |
| IL100621A0 (en) | Tetrazole derivatives,their preparation and pharmaceutical compositions containing them | |
| KR960007592A (ko) | 신규한 피롤로카바졸 | |
| DK1051177T3 (da) | Steroide 3-O-Sulfamatderivater som inhibitorer af östronsulfatase | |
| AR029509A1 (es) | Una composicion farmaceutica en base a un compuesto de platino (iv) y el uso de dicho compuesto para preparar medicamentos antitumorales | |
| NZ505614A (en) | Pentasaccharides and pharmaceutical compositions thereof, useful as anti blood clotting agnets | |
| NO943187D0 (no) | Indolderivater som steroid 5-alfa-reduktasehemmere | |
| UY26144A1 (es) | Nuevas formas cristalinas de un antibiótico macrolido. | |
| AR018888A1 (es) | Un derivado de testosterona, uso del mismo, una formulacion farmaceutica que comprende a dicho derivado y un kit para la anticoncepcion masculina | |
| PA8475701A1 (es) | Derivados de 3(2-oxo-[1,3']bipirrolidinil-3-ilidenmetil)-cephems | |
| KR940018351A (ko) | 노나테트라에노산 유도체 | |
| KR970704463A (ko) | 스트렙토그라민 유도체, 이의 제조 방법 및 이를 함유하는 약학 조성물(streptogramine derivatives, preparation of same and pharmaceutical compositions containing same) | |
| AR036462A1 (es) | Un compuesto esteroidal y su uso para la fabricacion de un medicamento | |
| BR9714965A (pt) | Composição oleosa de didropoliprenóis. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O E 13 DA LPI. |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |